Additionally, using bioinformatic analysis, we also found that the gene expression levels of RRM2 and ATP6V1C1 were upregulated in HCC patients, while that of FTCD and CYP2C9 were downregulated, and these results were consisted with our immunohistochemical results. This evidence concerns the gene CYP2C9 and hepatocellular carcinoma.